TABLE 4.
Patient Demographics
| Oct. 2009 | Jan. 2012 | Before/After Cohort | |
|---|---|---|---|
| n | 78 | 69 | 62 |
| Male, n (%) | 52 (67) | 43 (62) | 39 (63) |
| Median years old (range) | 18 (3–26) | 18 (3–25) | 16 (2–24) |
| Median years since transplant (range) | 4.9 (0.7–14.4) | 5.3 (0.6–16) | 4.6 (0.6–13.8) |
| Race/Ethnicity, n (%) | |||
| White non-Hispanic | 60 (77) | 52 (75) | 45 (73) |
| Black non-Hispanic | 16 (21) | 13 (19) | 15 (24) |
| Hispanic | 0 (0) | 1(1) | 0 (0) |
| Other | 2 (3) | 3 (4) | 2 (3) |
| Primary diagnosis | |||
| Aplasia/Hypoplasia/Dysplasia | 20 (26) | 17 (25) | 14 (23) |
| Obstructive/Reflux Nephropathy | 13 (17) | 11 (16) | 9 (15) |
| FSGS | 13 (17) | 9 (13) | 12 (19) |
| Chronic glomerulonephritis and nephrotic syndrome | 10 (13) | 7 (10) | 10 (16) |
| Cystic disease | 7 (9) | 5 (7) | 5 (8) |
| Other | 15 (19) | 20 (29) | 12 (19) |
| On sirolimus, n (%) | 37 (47) | 38 (55) | |
| On statin, n (%) | 15 (19) | 26 (38) |